CEO, Adam Christie, will present an overview of the company and its unique CALCIVIS imaging system, the first technology to allow the live visualisation of active tooth demineralisation, enabling a new standard of preventive care.
Adam Christie, CEO Tel: +44 (0)7795 600571
David Dible, Katja Stout, Citigate Dewe Rogerson Tel: +44 (0) 207 638 9571
CALCIVIS is an innovative medical devices company focused on revolutionising the management of dental caries or 'tooth decay'. CALCIVIS brings together novel biotechnology approaches and world-class device development expertise and is at the forefront of applying biotechnology to dentistry.
The CALCIVIS imaging system will, for the first time, allow the real-time detection and visualisation of calcium ions released by demineralising caries lesions in routine dental practice.
CALCIVIS began operations in 2012 and is based in Edinburgh, Scotland. The Company has been funded by Archangel Investors Limited and the Scottish Investment Bank, the investment arm of Scottish Enterprise. http://www.calcivis.com